» Articles » PMID: 32350723

Stool Antigen Testing, a Reliable Noninvasive Method of Assessment of Helicobacter Pylori Infection Among Patients with Gastro-duodenal Disorders in Cameroon

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2020 May 1
PMID 32350723
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several techniques such as invasive and noninvasive are used for the diagnosis of H. pylori infection.

Aim: The aim of this study was to compare the results of rapid urease test, stool antigen test and serology in diagnosing H. pylori infection in Cameroon.

Methods: Hundred patients (66 women and 34 men) were enrolled. Each patient gave a written consent. The study was approved by the local Ethical Committee of Medical Sciences and the institutional review board. From each patient, blood, stool and gastric biopsies samples were collected for H. pylori detection using three methods: stool antigen test, serology and rapid urease test (RUT), taken as gold standard. Statistical analysis was performed using Graph pad Prism 7.

Results: Helicobacter pylori infection was detected in 43%, 45% and 73% of patients based on the RUT, stool antigen test and serology, respectively. The difference was statistically significant between serology and RUT (P = 0.0026), but not between stool antigens test and RUT (P = 0.288). Taken RUT as gold standard, the sensitivity, specificity, positive and negative predictive values of stool antigens test and serology were 65.11, 70.17, 62.22 and 72.72%; 88.37, 40.35, 55.77 and 82.14%, respectively. The accuracy of stool antigen test and serology was 68 and 61%, respectively.

Conclusions: Our finding showed that stool antigen test can be used as a noninvasive method of assessment of H. pylori infection in our setting. Serological test can be used in screening; however, further diagnostic tests need to be carried out to confirm seropositive cases.

Citing Articles

Review of Methods for Detection in Kazakhstan.

Alyona L, Aizhan S, Aidana T, Alexey S, Yekaterina Y JGH Open. 2025; 9(1):e70101.

PMID: 39830988 PMC: 11740085. DOI: 10.1002/jgh3.70101.


Diagnostic value of IgG antibody and stool antigen tests for chronic Helicobacter pylori infections in Ibb Governorate, Yemen.

Al Ofairi B, Saeed M, Al-Qubaty M, Abdulkareem A, Al-Jahrani M Sci Rep. 2024; 14(1):7536.

PMID: 38553516 PMC: 10980813. DOI: 10.1038/s41598-024-58165-w.


Pangenome Analysis of Isolates from Selected Areas of Africa Indicated Diverse Antibiotic Resistance and Virulence Genes.

Yakubu B, Appiah E, Adu A Int J Genomics. 2024; 2024:5536117.

PMID: 38469580 PMC: 10927345. DOI: 10.1155/2024/5536117.


Lifestyle-based nomogram for identifying the Chaoshan inhabitants of China at high risk of Helicobacter pylori infection.

Lin Y, Wang P, Xue W, Zhou S, Huang Z, Li Y BMC Gastroenterol. 2023; 23(1):359.

PMID: 37853349 PMC: 10585980. DOI: 10.1186/s12876-023-02990-2.


The clinical significance of some serum tumor markers among chronic patients with Helicobacter pylori infections in Ibb Governorate, Yemen.

Saeed M, Al-Ofairi B, Hassan M, Al-Jahrani M, Abdulkareem A Infect Agent Cancer. 2023; 18(1):60.

PMID: 37828556 PMC: 10571253. DOI: 10.1186/s13027-023-00542-7.


References
1.
Brown L . Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2001; 22(2):283-97. DOI: 10.1093/oxfordjournals.epirev.a018040. View

2.
Ndip R, Malange Takang A, Ojongokpoko J, Luma H, Malongue A, Akoachere J . Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram. Trop Med Int Health. 2008; 13(6):848-54. DOI: 10.1111/j.1365-3156.2008.02062.x. View

3.
Blaser M, Kobayashi K, Cover T, Cao P, Feurer I, Perez-Perez G . Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer. 1993; 55(5):799-802. DOI: 10.1002/ijc.2910550518. View

4.
Liou J, Wu M, Lin J . Treatment of Helicobacter pylori infection: Where are we now?. J Gastroenterol Hepatol. 2016; 31(12):1918-1926. DOI: 10.1111/jgh.13418. View

5.
Lazar D, Taban S, Cornianu M, Faur A, Goldis A . New advances in targeted gastric cancer treatment. World J Gastroenterol. 2016; 22(30):6776-99. PMC: 4974579. DOI: 10.3748/wjg.v22.i30.6776. View